Literature DB >> 15250748

The measurement of contingent valuation for health economics.

Ahmed M Bayoumi1.   

Abstract

In health economics, contingent valuation is a method that elicits an individual's monetary valuations of health programmes or health states. This article reviews the theory and conduct of contingent valuation studies, with suggestions for improving the future measurement of contingent valuation for health economics applications. Contingent valuation questions can be targeted to any of the following groups: the general population, to value health insurance premiums for programmes; users of a health programme, to value the associated programme costs; or individuals with a disease, to evaluate health states. The questions can be framed to ask individuals how much they would pay to obtain positive changes in health status or avoid negative changes in health status ('willingness to pay'; WTP) or how much they would need to be paid to compensate for a decrease in health status or for foregoing an improvement in heath status ('willingness to accept'; WTA). In general WTP questions yield more accurate and precise valuations than WTA questions. Payment card techniques, with follow-up bidding using direct interviews with visual aids, are well suited for small contingent valuation studies. Several biases may be operative when assessing contingent valuation, including biases in the way participants are selected, the way in which the questions are posed, the way in which individuals interpret probabilities and value gains relative to losses, and the way in which missing or extreme responses are interpreted. An important aspect of all contingent valuation studies is an assessment of respondents' understanding of the evaluation method and the valuation task. Contingent valuation studies should measure the potential influence of biases, the validity of contingent valuation tests as measures of QOL, and the reliability and responsiveness of responses. Future research should address equity concerns associated with using contingent valuation and explore contingent valuation as a measure of utility for health states, particularly those that are minor or temporary.

Entities:  

Mesh:

Year:  2004        PMID: 15250748     DOI: 10.2165/00019053-200422110-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  22 in total

1.  Valuing the benefits of publicly-provided health care: does 'ability to pay' preclude the use of 'willingness to pay'?

Authors:  C Donaldson
Journal:  Soc Sci Med       Date:  1999-08       Impact factor: 4.634

Review 2.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 3.  Theory versus practice: a review of 'willingness-to-pay' in health and health care.

Authors:  J A Olsen; R D Smith
Journal:  Health Econ       Date:  2001-01       Impact factor: 3.046

4.  On hypothetical bias and calibration in cost-benefit studies.

Authors:  B Liljas; K Blumenschein
Journal:  Health Policy       Date:  2000-05       Impact factor: 2.980

Review 5.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

6.  Decision analysis with cumulative prospect theory.

Authors:  A M Bayoumi; D A Redelmeier
Journal:  Med Decis Making       Date:  2000 Oct-Dec       Impact factor: 2.583

7.  Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery.

Authors:  E Dalmau-Matarrodona
Journal:  Health Econ       Date:  2001-03       Impact factor: 3.046

8.  Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty.

Authors:  R A Hirth; B S Bloom; M E Chernew; A M Fendrick
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

9.  Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.

Authors:  L Lundberg; M Johannesson; M Silverdahl; C Hermansson; M Lindberg
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

10.  Measuring patient preferences by willingness to pay to avoid: the case of acute otitis media.

Authors:  P C Sorum
Journal:  Med Decis Making       Date:  1999 Jan-Mar       Impact factor: 2.583

View more
  30 in total

1.  Willingness to pay for health insurance among the elderly population in Germany.

Authors:  Jens-Oliver Bock; Dirk Heider; Herbert Matschinger; Hermann Brenner; Kai-Uwe Saum; Walter E Haefeli; Hans-Helmut König
Journal:  Eur J Health Econ       Date:  2014-12-20

2.  The general public's willingness to pay for tax increases to support unrestricted access to an Alzheimer's disease medication.

Authors:  Mark Oremus; Jean-Eric Tarride; Parminder Raina; Lehana Thabane; Gary Foster; Charlie H Goldsmith; Natasha Clayton
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

3.  A Longitudinal Investigation of Willingness to Pay for Health Insurance in Germany.

Authors:  Jens-Oliver Bock; André Hajek; Hermann Brenner; Kai-Uwe Saum; Herbert Matschinger; Walter Emil Haefeli; Ben Schöttker; Renate Quinzler; Dirk Heider; Hans-Helmut König
Journal:  Health Serv Res       Date:  2016-06-20       Impact factor: 3.402

Review 4.  Evaluating willingness-to-pay thresholds for dementia caregiving interventions: application to the tailored activity program.

Authors:  Eric Jutkowitz; Laura N Gitlin; Laura T Pizzi
Journal:  Value Health       Date:  2010-06-07       Impact factor: 5.725

5.  Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia.

Authors:  Centaine L Snoswell; Jennifer A Whitty; Liam J Caffery; Joanna Kho; Caitlin Horsham; Lois J Loescher; Dimitrios Vagenas; Nicole Gillespie; H Peter Soyer; Monika Janda
Journal:  Dermatology       Date:  2021-08-13       Impact factor: 5.366

6.  Patients' willingness-to-pay for an Alzheimer's disease medication in Canada.

Authors:  Mark Oremus; Jean-Eric Tarride; Eleanor Pullenayegum; Natasha Clayton; Parminder Raina
Journal:  Patient       Date:  2013       Impact factor: 3.883

7.  Patients' knowledge and attitude towards therapeutic reference pricing system in Slovenia.

Authors:  Nika Marđetko; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2016-08-08

Review 8.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

9.  Economic valuation of health care services in public health systems: a study about Willingness to Pay (WTP) for nursing consultations.

Authors:  Jesús Martín-Fernández; Ma Isabel del Cura-González; Gemma Rodríguez-Martínez; Gloria Ariza-Cardiel; Javier Zamora; Tomás Gómez-Gascón; Elena Polentinos-Castro; Francisco Javier Pérez-Rivas; Julia Domínguez-Bidagor; Milagros Beamud-Lagos; Ma Eugenia Tello-Bernabé; Juan Francisco Conde-López; Óscar Aguado-Arroyo; Ma Teresa Sanz-Bayona; Ana Isabel Gil-Lacruz
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Optimising corticosteroid injection for lateral epicondylalgia with the addition of physiotherapy: a protocol for a randomised control trial with placebo comparison.

Authors:  Brooke K Coombes; Leanne Bisset; Luke B Connelly; Peter Brooks; Bill Vicenzino
Journal:  BMC Musculoskelet Disord       Date:  2009-06-24       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.